Ukko
PrivateLast Round
Series C
Jan 8, 2026
Total Funding Raised
$92.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ukko is a biotechnology company that develops immunity-boosting proteins and novel immunotherapies aimed at treating food allergies and immune-mediated conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ukko Comparables
Compare Ukko with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IgGenix | 75% | |
| Nestlé | 69% | |
| Biolojic Design | 65% |
Ukko Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 8, 2026 | ||||
| Series B | Jan 27, 2021 | ||||
| Series A | Jul 24, 2017 |
Key People
Founding team and executive leadership
Ukko Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fall Line Capital | Series C, Series B |
| Israel Biotech Fund | Series C |
| Skyviews Life Science | Series B |
| TIME Ventures | Series B |
| Khosla Ventures | Series C, Series A, Series B |
| Innovation Endeavors | Series A, Series B |
| PeakBridge | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 17% QoQ, from 58 to 68 employees.
- May 17, 2026
Monthly visitors grew 108% MoM, reaching 2.5K.
Ukko Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ukko's valuation, stock price, and market status.
Is Ukko a public or private company?
Ukko is a private company.
What is the current stock price of Ukko?
Ukko is a private company with no public stock price. No recent secondary market data is available.
How much is Ukko worth (valuation)?
Valuation information for Ukko is not publicly available.
Can I buy Ukko stock?
Ukko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ukko's last funding round?
Ukko's most recent funding round was Series B on January 27, 2021.
Who are the main investors in Ukko?
Key investors in Ukko include Leaps by Bayer.
Will Ukko IPO soon?
No public IPO plans have been announced for Ukko.
How can I track Ukko secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ukko's secondary market activity and sign up for updates.